Roberta Buono

University of Naples Federico II — Italy

Biochemistry, Genetics and Molecular Biology · Life Sciences

14h-index1.6kcitations152works1.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Protein Degradation and Inhibitors(49), Multiple Myeloma Research and Treatments(36), Chronic Lymphocytic Leukemia Research(27), Cancer, Lipids, and Metabolism(21), Peptidase Inhibition and Analysis(20)

Publications152 total

Design and evaluation of dual-functional aptamer-peptide conjugates as a platform for targeted cancer therapy
European Journal of Pharmaceutical Sciences·2026Open Access
Pitavastatin counteracts venetoclax resistance mechanisms in acute myeloid leukemia by depleting geranylgeranyl pyrophosphate
2025Open Access
Synergistic effects of oncogene inhibition and pyruvate dehydrogenase kinase blockade in resistant NSCLC cells
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease·2025Open Access
Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response
Leukemia·2025· 7 citedOpen Access
IP15-12 A KIDNEY SPECIFIC FASTING-MIMICKING DIET INDUCES PODOCYTE REPROGRAMMING AND RESTORES RENAL FUNCTION IN GLOMERULOPATHY
The Journal of Urology·2025
Multi-Channel Designs
Focal Press eBooks·2025
Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer
Cancers·2024· 4 citedOpen Access
Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR and KRAS Mutant NSCLC
Preprints.org·2024· 2 citedOpen Access
Pitavastatin Potentiates Mitochondrial Dysfunction and Venetoclax Cytotoxicity in Acute Myeloid Leukemia Cells
Blood·2024
A Novel Approach Combining Type II JAK Inhibitor Chz-868 with Nutrient Restriction to Augment Cell Death in Philadelphia like Acute Lymphoblastic Leukemia
Blood·2024Open Access
A kidney-specific fasting-mimicking diet induces podocyte reprogramming and restores renal function in glomerulopathy
Science Translational Medicine·2024· 6 cited
A Kidney-Specific Fasting-Mimicking Diet Induces Podocyte Reprogramming and Restores Kidney Function in Glomerulopathy
Journal of the American Society of Nephrology·2024
A phase 1 study adding pitavastatin to venetoclax therapy in AML and CLL/SLL: a mechanism-based drug repurposing strategy
Blood Neoplasia·2024· 6 citedOpen Access
Chemoresistance of <i>TP53</i> mutant AML requires the mevalonate byproduct, GGPP, for regulation of ROS and induction of a mitochondria stress response
2024Open Access
SFigure7 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024Open Access
SFigure2 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024Open Access
SFigure6 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024Open Access
SFigure1 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024Open Access
Supplementary Data from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024Open Access
SFigure4 from Cyclic Fasting–Mimicking Diet Plus Bortezomib and Rituximab Is an Effective Treatment for Chronic Lymphocytic Leukemia
2024Open Access
page 1 of 8Next →

Frequent Co-authors

Roberta Buono(17), Fabio Benigni(11), Sharmila Mallya(11), Valter D. Longo(10), Francesco Montorsi(10), Petter Hedlund(9), Dennis Juarez(9), Madeleine Duong(9), Madhuri Paul(9), Shannon M. Matulis(8), Vikas A. Gupta(8), Jacob Yudiono(8), Grace Diep(8), Peter Hsin(8), Alexander Lu(8), Sang Mi Suh(8), Vy M. Dong(8), Andrew W. Roberts(8), Joel Johansson(8), Muhammad Jalaluddin(8)